Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive versus empirical antifungal therapy in pediatric cancer patients with febrile neutropenia
RBR-3m9d74Phase 3Completed
- Sponsor
- National Fund for Scientific and Technological Development
- Start
- Jul 2013
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of liposomal amphotericin b and voriconazole in invasive mycoses (2 arms), sponsored by National Fund for Scientific and Technological Development. Started Jul 2013; status: completed.
02
Drugs
liposomal amphotericin bvoriconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on RBR-3m9d74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3m9d74.